Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2203-2208

  Hsieh, Yao Yuan ^a,b   Chang, Chi Chen ^b   Wang, Yu Kuo ^c   Hsu, Kung Hao ^b   Chen, Chih Ping ^d   Hsu, Chin Mu ^e   Tsai, Fuu Jen ^e,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Hsieh Yao Yuan Womens' Hospital   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

Cadherin; Insulin like growth factor; Leiomyoma; Myeloperoxidase; Polymorphism; Urokinase; Xeroderma pigmentosum

Indexed keywords

GENOMIC DNA; MYELOPEROXIDASE; SOMATOMEDIN B; UROKINASE; UVOMORULIN; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA ISOLATION; ELECTROPHORESIS; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; LEIOMYOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RESTRICTION MAPPING;

ADULT; CADHERINS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LEIOMYOMA; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; UTERINE NEOPLASMS; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 77955064517     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cramer DW: Epidemiology of myomas. Semin Reprod Endocrinol 10: 320-324, 1992.
2. Hsieh YY, Chang CC, Tsai FJ et al: Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril 79: 96-99, 2003.
3. Hsieh YY, Chang CC, Tsai FJ et al: Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertil Steril 82: 1177-1181, 2004.
4. Hsieh YY, Chang CC, Hsu CW et al: Gene transfections with p53 and p21 inhibit cell proliferation, collagen type I, leukemia inhibitory factor, and tumor necrosis factor-alpha expression in leiomyoma cells. Fertil Steril 81: 1665-1670, 2004.
5. Vu TH, Yballe C, Boonyanit S et al: Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J Clin Endocrinol Metab 80: 1670-1676, 1995.
6. El-Badry OM, Helman LJ, Chatten J et al: Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87: 648-657, 1991.
7. Hsieh YY, Chang CC, Bau DT et al: The p21 codon 31*C- and DRD2 codon 313*T-related genotypes/alleles, but not XRCC1 codon 399, hOGG1 codon 326, and DRD1-48 polymorphisms, are correlated with the presence of leiomyoma. Fertil Steril 91: 869-877, 2009.
8. Kim HC, Wheeler JM, Kim JC et al: The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut 47: 262-267, 2000.
9. Saito K, Nagashima M, Iwata M et al: The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumors. Thromb Res 58: 355-366, 1990.
10. Ishchenko IG, Mishchenko AL, Landekhovskii ID et al: Changes in the hemostatic system in anomalous uterine hemorrhages and uterine myoma at perimenopause. Akush Ginekol (Mosk) 6: 54-58, 1993.
11. Bau DT, Tsai MH, Huang CY et al: Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol 50: 294-300, 2007.
12. Ferriani RA, Charnock-Jones DS, Prentice A et al: Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod 8: 11-16, 1993.
13. Vollenhoven BJ, Herington AC and Healy DL: Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 76: 106-110, 1993.
14. Friedman AJ, Rein MS, Pandian MR et al: Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo. Fertil Steril 53: 250-253, 1990.
15. Magri KA, Benedict MR, Ewton DZ et al: Negative feedback regulation of insulin-like growth factor-II gene expression in differentiating myoblasts in vitro. Endocrinology 135: 53-62, 1994.
16. Chen WC, Chen HY, Wu HC et al: Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res 31: 218-222, 2003.
17. Tsai FJ, Wu HC, Chen HY et al: Association of E-cadherin gene 3′-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 70: 278-281, 2003.
18. Chesire DR, Ewing CM, Sauvageot J et al: Detection and analysis of beta-catenin mutations in prostate cancer. Prostate;45:323-334,2000
19. Hsieh YY, Chang CC, Tsai FJ et al: Glutathione 5-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis. Mol Hum Reprod: 70: 713-717, 2004.
20. Chevrier I, Stucker I, Houllier AM et al: Myeloperoxidase, new polymorphisms and relation with lung cancer risk. Pharmacogenetics 13: 729-739, 2003.
21. Tsai FJ, Lin CC, Lu HF et al: Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis. Urology 59: 458-461, 2002.
22. Bruse C, Bergqvist A, Carlstrom K et al: Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil Steril 70: 821-826, 1998.
23. Takahashi K, Kawamura N, Tsujimura A et al: Association of the shrinkage of uterine leiomyoma treated with GnRH agonist and deletion of long arm of chromosome 7. Int J Oncol 18: 1259-1263, 2001.
24. Camps C, Sarries C, Roig B et al: Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin- treated advanced non-small cell lung cancer patients. Clin Lung Cancer 4: 237-241, 2003.